Enzyme reducing each of the substrates are measured by monitoring the concomitant oxidation of NADPH by NfsA and NADH by NfsB in a fluorescence based assay. The reduction in fluorescence due to the NADH oxidation (excitation 350 nm, emission 460 nm) and NADPH oxidation (excitation 340 nm, emission 485 nm) is recorded using a TECAN Infinite M200Pro spectrophotometer, in half area solid black microtiter plates. This change in fluorescence directly corelates to the reduction of the nitro-compounds in the reaction. The NfsA assays is performed by initiating the reactions with 40 μM NADPH and 10 nM NfsA in 50 mM Tris-HCl (pH 7.4), 5 mM EDTA against 20 μM substrate (5 μl of compounds/substrate dissolved in 100% DMSO) in a total reaction volume of 100 μl at 25 °C. Similarly, the NfsB assay is also performed by initiating the reactions with 40 μM NADH and 70 nM NfsB in 50 mM Tris-HCl (pH 7.4), 5 mM EDTA against 20 μM substrate in a total reaction volume of 100 μl. These are the optimal conditions arrived at by titrating the enzyme between 2.5 nM–100 nM, NADH/NADPH between 10 and 100 µM, DMSO between 0 and 15% for its tolerance and solubility of the compounds/substrate. All reactions are performed in replicates of two or more and the fluorescence measurements are made at 10 second intervals for 5–10 minutes.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.